Neuronal Plasticity and Functional Recovery After Ischemic Stroke

REFERENCES

• American Heart Association. Heart Disease and Stroke Statistics- 2007 Update. Dallas, TX: Ameri-can Heart Association; 2007.
   Google Scholar
• Kelly-Hayes M, Beiser A, Kase CS, Scaramucci A, D'Agostino RB, Wolf PA. The influence of gender and age on disability following ischemic stroke: The Framingham Study. J Stroke Cerebrovasc Dis. 2003;12(3):119–126.
   PubMedGoogle Scholar
• Hillis AE. Neurobiology of unilateral spatial neglect. Neuroscientist. 2006;12(2):153–163.
   PubMed Web of Science ®Google Scholar
• Bambauer KZ, Johnston SC, Bambauer DE, Zivin JA. Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol. 2006;63(5):661–664.
   PubMed Web of Science ®Google Scholar
• Weintraub MI. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire. Stroke. 2006;37(7):1917–1922.
   PubMed Web of Science ®Google Scholar
• Cheng YD, Al-Khoury L, Zivin JA. Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx. 2004;1(1):36–45.
   PubMedGoogle Scholar
• Savitz SI. A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke. Exp Neurol. 2007;205(1): 20–25.
   PubMed Web of Science ®Google Scholar
• Ginsberg MD. Life after cerovive: a personal per-spective on ischemic neuroprotection in the post-NXY-059 era. Stroke. 2007;38(6):1967–1972.
   PubMed Web of Science ®Google Scholar
• Faden Al, Stoica B. Neuroprotection: challenges and opportunities. Arch Neurol. 2007;64(6):794–800.
   PubMed Web of Science ®Google Scholar
• Young AR, Ali C, Duretete A, Vivien D. Neuroprotection and stroke: time for a compro-mise. J Neurochem. 2007;103(4):1302–1309.
   PubMed Web of Science ®Google Scholar
• Savitz SI, Fisher M. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann Neurol. 2007;61(5):396–402.
   PubMed Web of Science ®Google Scholar
• Duncan PW, Lai SM, Keighley J. Defining post-stroke recovery: implications for design and interpretation of drug trials. Neuropharmacology. 2000;39(5):835–841.
   PubMed Web of Science ®Google Scholar
• Emerick AJ, Kartje GL. Behavioral recovery and ana-tomical plasticity in adult rats after cortical lesion and treatment with monoclonal antibody IN-1. Behav Brain Res. 2004;152(2):315–325.
   PubMed Web of Science ®Google Scholar
• Emerick AJ, Neafsey EJ, Schwab ME, Kartje GL. Func-tional reorganization of the motor cortex in adult rats after cortical lesion and treatment with mono-clonal antibody IN-1.1 Neurosci. 2003;23(12):4826–4830.
   PubMed Web of Science ®Google Scholar
• Dijkhuizen RM, Singhal AB, Mandeville JB, et al. Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. J Neurosci. 2003;23(2): 510–517.
   PubMed Web of Science ®Google Scholar
• Cramer SC, Nelles G, Benson RR, et al. A functional MRI study of subjects recovered from hemiparetic stroke. Stroke. 1997;28(12):2518–2527.
   PubMed Web of Science ®Google Scholar
• Rossini PM, Altamura C, Ferreri F, et al. Neuroimaging experimental studies on brain plas-ticity in recovery from stroke. Eura Medicophys. 2007;43(2):241–254.
   PubMedGoogle Scholar
• Tecchio F, Zappasodi F, Tombini M, et al. Brain plasticity in recovery from stroke: an MEG assess-ment. Neurolmage. 2006;32(3):1326–1334.
   PubMed Web of Science ®Google Scholar
• Johansson BB. Regeneration and plasticity in the brain and spinal cord. J Cereb Blood Row Metab. 2007;27(8):1417–1430.
   PubMed Web of Science ®Google Scholar
• Caroni P, Schwab ME. Two membrane protein frac-tions from rat central myelin with inhibitory proper-ties for neurite growth and fibroblast spreading. J Cell Biol. 1988106(4):1281–1288.
   Google Scholar
• Schwab ME. Nogo and axon regeneration. Curr Opin Neurobiol. 2004;14(1):118–124.
   PubMed Web of Science ®Google Scholar
• Fournier AE, GrandPre T, Strittmatter SM. Identifica-tion of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 2001;409(6818):341–346.
   PubMed Web of Science ®Google Scholar
• Lee JK, Kim JE, Sivula M, Strittmatter SM. Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci. 2004; 24(27):6209–6217.
   PubMed Web of Science ®Google Scholar
• Wang KC, Kim JA, Sivasankaran R, Segal R, He Z. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature. 2002; 420(6911):74–78.
   PubMed Web of Science ®Google Scholar
• Park JB, Yiu G, Kaneko S, et al. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibi-tors. Neuron. 2005;45(3):345–351.
   PubMed Web of Science ®Google Scholar
• Shao Z, Browning IL, Lee X, et al. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron. 2005;45(3):353–359.
   PubMed Web of Science ®Google Scholar
• Mi S, Lee X, Shao Z, et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci. 2004;7(3):221–228.
   PubMed Web of Science ®Google Scholar
• Yiu G, He Z. Glial inhibition of CNS axon regenera-tion. Nat Rev Neurosci. 2006;7(8):617–627.
   PubMed Web of Science ®Google Scholar
• Cafferty WB, Strittmatter SM. The Nogo-Nogo re-ceptor pathway limits a spectrum of adult CNS axonal growth. J Neurosci. 2006;26(47)1 2242–12250.
   Google Scholar
• Caroni P, Schwab ME. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron. 1988;1(1):85–96.
   PubMed Web of Science ®Google Scholar
• Buchli AD, Rouiller E, Mueller R, Dietz V, Schwab ME. Repair of the injured spinal cord. A joint ap-proach of basic and clinical research. Neurodeqener Dis. 2007;4(1):51–56.
   PubMed Web of Science ®Google Scholar
• Whishaw IQ. Loss of the innate cortical engram for action patterns used in skilled reaching and the development of behavioral compensation following motor cortex lesions in the rat. Neuropharmacoloqy. 2000;39(5):788–805.
   PubMed Web of Science ®Google Scholar
• Tsai SY, Markus TM, Andrews EM, et al. Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke. Exp Brain Res. 2007;182(2):261–266.
   PubMed Web of Science ®Google Scholar
• Seymour AB, Andrews EM, Tsai SY, et al. Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats. J Cereb Blood Row Metab. 2005;25:1366–1375.
   PubMed Web of Science ®Google Scholar
• Markus TM, Tsai SY, Bollnow MR, et al. Recovery and brain reorganization after stroke in adult and aged rats. Ann Neurol. 2005;58(6):950–953.
   PubMed Web of Science ®Google Scholar
• Papadopoulos CM, Tsai SY, Alsbiei T., O'Brien TE, Schwab ME, Kartje GL. Functional recovery and neuroanatomical plasticity following middle cere-bral artery occlusion and IN-1 antibody treatment in the adult rat. Ann Neurol. 2002;51(4):433–441.
   PubMed Web of Science ®Google Scholar
• Wiessner C, Bareyre FM, Allegrini PR, et al. Anti-Nogo-A antibody infusion 24 hours after experi-mental stroke improved behavioral outcome and corticospinal plasticity in normotensive and sponta-neously hypertensive rats. J Cereb Blood Row Metab. 2003;23(2)1 54–165.
   Google Scholar
• Kartje GL, Schulz MK, Lopez-Yunez A., Schnell L., Schwab ME.. Corticostriatal plasticity is restricted by myelin-associated neurite growth inhibitors in the adult rat. Ann Neurol. 1999;45(6):778–786.
   PubMed Web of Science ®Google Scholar
• Papadopoulos CM, Tsai SY, Cheatwood IL, et al. Dendritic plasticity in the adult rat following middle cerebral artery occlusion and Nogo-a neutralization. Cereb Cortex. 2006;16(4):529–536.
   PubMed Web of Science ®Google Scholar
• Irving EA, Vinson M, Rosin C, et al. Identification of neuroprotective properties of anti-MAG antibody: a novel approach for the treatment of stroke? J Cereb Blood Row Metab. 2005;25(1):98–107.
   PubMed Web of Science ®Google Scholar
• Reep RL, Corwin JV, Cheatwood IL., Van Vleet TM, Heilman KM, Watson RT. A rodent model for investi-gating the neurobiology of contralateral neglect. Cogn Behav Neurol. 2004;17(4):191–194.
   PubMedGoogle Scholar
• Brenneman MM, Wagner SJ, Cheatwood IL, et al. Nogo-A inhibition induces recovery from neglect in rats. Behav Brain Res. In press.
   Web of Science ®Google Scholar
• Heilman KM, Valenstein E, Watson RT. Neglect and related disorders. Semin Neurol. 2000;20(4):463–470.
   PubMed Web of Science ®Google Scholar
• Bliss T, Guzman R, Daadi M, Steinberg GK. Cell transplantation therapy for stroke. Stroke. 2007;38(2 suppl):817–826.
   PubMed Web of Science ®Google Scholar
• Newman MB, Misiuta I, Willing AE, et al. Tumorige-nicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. Stem Cells Dev. 2005;14(1):29–43.
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Steinberg GK, Wechsler L, et al. Neu rotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. Neurosurq. 2005;103(1):38–45.
   PubMed Web of Science ®Google Scholar
• Dobkin BH. Behavioral, temporal, and spatial targets for cellular transplants as adjuncts to rehabilitation for stroke. Stroke. 2007;38(2 suppl):832–839.
   PubMed Web of Science ®Google Scholar
• Steindler DA. Stem cells, regenerative medicine, and animal models of disease. liar J. 2007;48(4):323–338.
   Google Scholar
• Chen J, Chopp M. Neurorestorative treatment of stroke: cell and pharmacological approaches. NeuroRx. 2006;3(4):466–473.
   PubMedGoogle Scholar
• Kolb B, Morshead C, Gonzalez C, et al. Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats. J Cereb Blood Row Metab. 2007;27(5):983–997.
   PubMed Web of Science ®Google Scholar
• Ziemann U, Meintzschel F, Korchounov A, Ilic TV. Pharmacological modulation of plasticity in the hu-man motor cortex. Neurorehabil Neural Repair. 2006;20(2):243–251.
   PubMed Web of Science ®Google Scholar
• Kuczenski R, Segal DS. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther. 2001;296(3): 876–883.
   PubMed Web of Science ®Google Scholar
• Stroemer RP, Kent TA, Hulsebosch CE. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke. 1998;29(11): 2381–2393; discussion 2393–2395.
   Web of Science ®Google Scholar
• Ramic M, Emerick AJ, Bollnow MR., O'Brien TE, Tsai SY, Kartje GL. Axonal plasticity is associated with motor recovery following amphetamine treatment combined with rehabilitation after brain injury in the adult rat. Brain Res. 2006;1111(1):176–186.
   PubMed Web of Science ®Google Scholar
• Sonde L, Lokk J. Effects of amphetamine and/or L-dopa and physiotherapy after stroke-a blinded randomized study. Acta Neurol Scand. 2007; 115(1):55–59.
   PubMed Web of Science ®Google Scholar
• Platz T, Kim IH, Engel U, Pinkowski C, Eickhof C, Kutzner M. Amphetamine fails to facilitate motor performance and to enhance motor recovery among stroke patients with mild arm paresis: in-terim analysis and termination of a double blind, randomised, placebo-controlled trial. Restor Neurol Neurosci. 2005;23(5-6):271–280.
   PubMed Web of Science ®Google Scholar
• Gladstone DJ, DaneIls CJ, Armesto A, et al. Physio-therapy coupled with dextroamphetamine for reha-bilitation after hemiparetic stroke: a randomized, double-blind, placebo-controlled trial. Stroke. 2006;37(1):179–185.
   PubMed Web of Science ®Google Scholar
• Martinsson L, Hardemark H, Eksborg S. Amphet-amines for improving recovery after stroke. Cochrane Database Syst Rev. 2007(1):CD002090.
   Google Scholar
• Dromerick AW, Lum PS, Hidler J. Activity-based therapies. NeuroRx. 2006;3(4):428–438.
   PubMedGoogle Scholar
• Mark VW, Taub E, Morris DM. Neuroplasticity and constraint-induced movement therapy. Eura Medicophys. 2006;42(3):269–284.
   PubMedGoogle Scholar
• Morris DM, Taub E, Mark VW. Constraint-induced movement therapy: characterizing the intervention protocol. Eura Medicophys. 2006;42(3):257–268.
   PubMedGoogle Scholar
• Taub E, Uswatte G, Mark VW, Morris DM. The learned nonuse phenomenon: implications for reha-bilitation. Eura Medicophys. 2006;42(3):241–256.
   PubMedGoogle Scholar
• Cramer SC. The EXCITE trial: a major step forward for restorative therapies in stroke. Stroke. 2007;38(7):2204–2205.
   PubMed Web of Science ®Google Scholar
• Luft AR, Hanley DF. Stroke recovery-moving in an EXCITE-ing direction. JAMA. 2006;296(17):2141–2143.
   PubMed Web of Science ®Google Scholar
• Wolf SL, Winstein CJ, Miller JP, et al. Effect of con-straint-induced movement therapy on upper ex-tremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. /AMA. 2006;296(17):2095–2104.
   PubMed Web of Science ®Google Scholar
• Dobkin BH. Confounders in rehabilitation trials of task-oriented training: lessons from the designs of the EXCITE and SCILT multicenter trials. Neurorehabil Neural Repair. 2007;21(1):3–13.
   PubMed Web of Science ®Google Scholar
• Liepert J, Bauder H, Wolfgang HR, Miltner WH, Taub E, Weiller C. Treatment-induced cortical reorganiza-tion after stroke in humans. Stroke. 2000;31(6): 1210–1216.
   PubMed Web of Science ®Google Scholar
• Schaechter JD, Kraft E, Hilliard TS, et al. Motor re-covery and cortical reorganization after constraint-induced movement therapy in stroke patients: a preliminary study. Neurorehabil Neural Repair. 2002;16(4):326–338.
   PubMed Web of Science ®Google Scholar
• Schaechter JD. Motor rehabilitation and brain plas-ticity after hemiparetic stroke. Prog Neurobiol. 2004;73(1):61–72.
   PubMed Web of Science ®Google Scholar
• Taub E, Griffin A, Nick J, Gammons K, Uswatte G, Law CR. Pediatric CI therapy for stroke-induced hemiparesis in young children. Dev Neurorehabil. 2007;10(1):3–18.
   PubMedGoogle Scholar
• Z'Graggen WI, Fouad K, Raineteau O, Metz GA, Schwab ME, Kartje GL. Compensatory sprouting and impulse rerouting after unilateral pyramidal tract lesion in neonatal rats. J Neurosci. 2000; 20(17):6561–6569.
   PubMed Web of Science ®Google Scholar
• O'Malley MK, Ro T, Levin HS. Assessing and induc-ing neuroplasticity with transcranial magnetic stimulation and robotics for motor function. Arch Phys Med Rehabil. 2006;87(12 suppl 2):559–66.
   Google Scholar
• Volpe BT, Ferraro M, Lynch D, et al. Robotics and other devices in the treatment of patients recover-ing from stroke. Curr Neurol Neurosci Rep. 2005; 5(6):465–470.
   PubMedGoogle Scholar
• Siekierka EM, Eng K, Bassetti C, et al. New technolo-gies and concepts for rehabilitation in the acute phase of stroke: a collaborative matrix. Neurodegener Dis. 2007;4(1):57–69.
   PubMed Web of Science ®Google Scholar
• Prange GB, Jannink MJ, Groothuis-Oudshoorn CG., Hermens HJ., Ijzerman MJ.. Systematic review of the effect of robot-aided therapy on recovery of the hemiparetic arm after stroke. J Rehabil Res Dev. 2006;43(2):171–184.
   PubMed Web of Science ®Google Scholar